A large-scale parallel sequencing analysis of 9 cases of secretory breast cancer, including one ductal carcinoma in situ, showed that there were no additional typical mutations in breast cancer except ETV6-NTRK3 gene mutation in all cases, while the mutation burden was very low [23]. The gene discussed is ETV6; the disease is ductal breast carcinoma in situ.